TrialNeuro-oncology2024

3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.

Emeline Tabouret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.